Janssen's full clinical studies to put on new schizophrenia drug.

Published: 2006-01-26 06:57:00

Updated: 2006-01-26 06:57:00

Janssen Korea put a full clinical study for the new generation of schizophrenia drug, Paliperidone, especially focusing on 5 of phase III studies at 20 test centers and 1 of phase I study, the total 6 studies in Korea.

Janssen Korea said on Jan. 23 that the phase III studies would take place ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK